Molecules 2013, 18(5), 6113-6127; doi:10.3390/molecules18056113
Article

The Ameliorative Effect of Sophoricoside on Mast Cell-Mediated Allergic Inflammation in Vivo and in Vitro

1,†email, 2,†email, 2email, 3email, 4email, 5email, 6,†email and 5,†,* email
Received: 11 March 2013; in revised form: 7 May 2013 / Accepted: 10 May 2013 / Published: 22 May 2013
(This article belongs to the Special Issue Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Sophoricoside exhibits numerous pharmacological effects, including anti- inflammatory and anti-cancer actions, yet the exact mechanism that accounts for the anti-allergic effects of sophoricoside is not completely understood. The aim of the present study was to elucidate whether and how sophoricoside modulates the mast cell-mediated allergic inflammation in vitro and in vivo. We investigated the pharmacological effects of sophoricoside on both compound 48/80 or histamine-induced scratching behaviors and 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis in mice. Additionally, to find a possible explanation for the anti-inflammatory effects of sophoricoside, we evaluated the effects of sophoricoside on the production of histamine and inflammatory cytokines and activation of nuclear factor-κB (NF-κB) and caspase-1 in phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated human mast cells (HMC-1). The finding of this study demonstrated that sophoricoside reduced compound 48/80 or histamine-induced scratching behaviors and DNCB-induced atopic dermatitis in mice. Additionally, sophoricoside inhibited the production of inflammatory cytokines as well as the activation of NF-κB and caspase-1 in stimulated HMC-1. Collectively, the findings of this study provide us with novel insights into the pharmacological actions of sophoricoside as a potential molecule for use in the treatment of allergic inflammation diseases.
Keywords: sophoricoside; inflammatory cytokine; mast cells; allergic inflammation
PDF Full-text Download PDF Full-Text [1073 KB, uploaded 18 June 2014 20:05 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Kim, S.-J.; Lee, G.-Y.; Jung, J.-W.; Oh, S.-R.; Ahn, E.-M.; Kim, S.-H.; Hong, S.-H.; Um, J.-Y. The Ameliorative Effect of Sophoricoside on Mast Cell-Mediated Allergic Inflammation in Vivo and in Vitro. Molecules 2013, 18, 6113-6127.

AMA Style

Kim S-J, Lee G-Y, Jung J-W, Oh S-R, Ahn E-M, Kim S-H, Hong S-H, Um J-Y. The Ameliorative Effect of Sophoricoside on Mast Cell-Mediated Allergic Inflammation in Vivo and in Vitro. Molecules. 2013; 18(5):6113-6127.

Chicago/Turabian Style

Kim, Su-Jin; Lee, Gil-Yong; Jung, Ji-Wook; Oh, Sa-Rang; Ahn, Eun-Mi; Kim, Sung-Hoon; Hong, Seung-Heon; Um, Jae-Young. 2013. "The Ameliorative Effect of Sophoricoside on Mast Cell-Mediated Allergic Inflammation in Vivo and in Vitro." Molecules 18, no. 5: 6113-6127.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert